Stempoint Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-317,060
Closed -$16.2M 57
2024
Q4
$16.2M Buy
317,060
+103,245
+48% +$5.28M 4.05% 5
2024
Q3
$10.9M Sell
213,815
-337,280
-61% -$17.2M 3.27% 9
2024
Q2
$24.7M Sell
551,095
-68,694
-11% -$3.08M 7.25% 4
2024
Q1
$29M Buy
619,789
+370,214
+148% +$17.3M 7.67% 2
2023
Q4
$8.88M Buy
+249,575
New +$8.88M 2.37% 14